Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) FCF Margin (2020 - 2025)

Pulse Biosciences has reported FCF Margin over the past 4 years, most recently at 15377.91% for Q3 2025.

  • Quarterly results put FCF Margin at 15377.91% for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 63298.84% (changed N/A YoY), and the annual figure for FY2022 was 6773.43%, down 290743.0%.
  • FCF Margin for Q3 2025 was 15377.91% at Pulse Biosciences, down from 4364.33% in the prior quarter.
  • Over the last five years, FCF Margin for PLSE hit a ceiling of 10296.49% in Q1 2021 and a floor of 15377.91% in Q3 2025.
  • Median FCF Margin over the past 3 years was 2353.14% (2021), compared with a mean of 2003.37%.
  • Biggest five-year swings in FCF Margin: surged 15037994bps in 2021 and later plummeted -1420174bps in 2022.
  • Pulse Biosciences' FCF Margin stood at 1503.39% in 2021, then tumbled by -190bps to 4364.33% in 2022, then tumbled by -252bps to 15377.91% in 2025.
  • The last three reported values for FCF Margin were 15377.91% (Q3 2025), 4364.33% (Q2 2022), and 3905.25% (Q1 2022) per Business Quant data.